Company: MYSZ
Filing Date: 2025-03-27
Form Type: 10-K
Source: 0001641172-25-000990
Chunk: 694

Company: My Size, Inc.
Filing Date: 2025-03-27
Form: 10-K
Item: Item 7
Chunk 694
---
. Based on consideration of these factors, the Company recorded
a valuation allowance to reduce deferred tax assets to the amount supported by future reversals of existing taxable temporary differences
at December 31, 2024 and 2023.

    e.
    Theoretical
    tax

The
following presents the adjustment between the theoretical income tax benefit that would result from applying the U.S. federal statutory
income tax rate to loss before income taxes amount and the reported income tax benefit included in the financial statements:

SCHEDULE
OF COMPONENTS OF INCOME TAX EXPENSES BENEFITS 

    2024  
    2023 

    December
    31, 

    2024  
    2023 

    Loss
    before income taxes 
     3,995  
     6,713 
  
    Statutory
    income tax rate 
     21%  
     21%
  
    Computed
    “expected” income tax benefit 
     839  
     1,410 
  
    Foreign
    tax rate differences 
     60  
     73 
  
    Exchange
    rate differences 
     6  
     47 
  
    Nondeductible
    expenses 
     42  
     (41)
  
    Impairment
    of goodwill 
     (152) 
     (168)
  
    Change
    in valuation allowance 
     (795) 
     (988)
  
    Income
    tax benefit 
     -  
     333 

The
entire income tax benefit is a deferred tax benefit.

    F-21

MY
SIZE, INC. AND ITS SUBSIDIARIES

NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS

U.S.
dollars in thousands (except share data and per share data)

NOTE
13 - SHAREHOLDERS’ EQUITY 

    a.
    Common
                                            stock confers upon their holders the right to receive notice to participate and vote in general
                                            meetings of the Company, and the right to receive dividends if declared.

    b.
    On
                                            April 19, 2024, the Company effected a one-for-eight reverse stock split of its common stock
                                            (the “Reverse Stock Split”) with the Company’s shares beginning trading
                                            on a post-split basis on the Nasdaq Capital Market on April 23, 2024